{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Antiarrhytmic",
      "Anticoaculant",
      "Aspirin",
      "COVID-19",
      "Colchicine",
      "Diabetes",
      "NSAID",
      "RAAS",
      "Statin",
      "Vitamin D"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [
    [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Grodzicki"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Strandberg"
      }
    ]
  ],
  "PMID": "34031865",
  "DateCompleted": {
    "Year": "2021",
    "Month": "08",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "05",
        "Day": "25"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s41999-021-00504-5"
    ],
    "Journal": {
      "ISSN": "1878-7649",
      "JournalIssue": {
        "Volume": "12",
        "Issue": "4",
        "PubDate": {
          "Year": "2021",
          "Month": "Aug"
        }
      },
      "Title": "European geriatric medicine",
      "ISOAbbreviation": "Eur Geriatr Med"
    },
    "ArticleTitle": "Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications.",
    "Pagination": {
      "StartPage": "725",
      "EndPage": "739",
      "MedlinePgn": "725-739"
    },
    "Abstract": {
      "AbstractText": [
        "In the pathogenesis of severe COVID-19 complications, derangements of renin-angiotensin-aldosterone system (RAAS), vascular endothelial dysfunction leading to inflammation and coagulopathy, and arrhythmias play an important role. Therefore, it is worth considering the use of currently available drugs to protect COVID-19 patients with cardiovascular diseases.",
        "We review the current experience of conventional cardiovascular drugs [angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers, anticoagulants, acetosalicylic acid, antiarrhythmic drugs, statins] as well as some other drug classes (antidiabetic drugs, vitamin D and NSAIDs) frequently used by older patients with cardiovascular diseases. Data were sought from clinical databases for COVID-19 and appropriate key words. Conclusions and recommendations are based on a consensus among all authors.",
        "Several cardiovascular drugs have a potential to protect patients with COVID-19, although evidence is largely based on retrospective, observational studies. Despite propensity score adjustments used in many analyses observational studies are not equivalent to randomised controlled trials (RCTs). Ongoing RCTs include treatment with antithrombotics, pulmonary vasodilators, RAAS-related drugs, and colchicine. RCTs in the acute phase of COVID-19 may not, however, recognise the benefits of long term anti-atherogenic therapies, such as statins.",
        "Most current cardiovascular drugs can be safely continued during COVID-19. Some drug classes may even be protective. Age-specific data are scarce, though, and conditions which are common in older patients (frailty, comorbidities, polypharmacy) must be individually considered for each drug group."
      ],
      "CopyrightInformation": "\u00a9 2021. The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Medicine, Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Servi\u00e7o de Medicina III, Hospital Pulido Valente, CHULNUniversity of LisbonUniversidade de Lisboa, Lisbon, Portugal."
          }
        ],
        "LastName": "Alves",
        "ForeName": "Mariana",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Internal Medicine, Hospital Curry Cabral, Centro Hospitalar Universit\u00e1rio de Lisboa Central, Lisbon, Portugal."
          }
        ],
        "LastName": "Fernandes",
        "ForeName": "Mar\u00edlia Andreia",
        "Initials": "MA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Istanbul Medical School, Department of Internal Medicine, Division of Geriatrics, Istanbul University, Capa, 34093, Istanbul, Turkey."
          }
        ],
        "LastName": "Bahat",
        "ForeName": "G\u00fclistan",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Geriatrics and FHU CARTAGE-PROFILES, CHRU de Nancy and INSERM 1116, Universit\u00e9 de Lorraine, Vandoeuvre-l\u00e8s-Nancy, France."
          }
        ],
        "LastName": "Benetos",
        "ForeName": "Athanase",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Geriatrics, Centre Hospitalier de Wallonie Picarde, Tournai, Belgium."
          }
        ],
        "LastName": "Clemente",
        "ForeName": "Hugo",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Cracow, Poland."
          }
        ],
        "LastName": "Grodzicki",
        "ForeName": "Tomasz",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, CIBER-CV. Universidad Europea, Universidad Complutense, Madrid, Spain."
          }
        ],
        "LastName": "Mart\u00ednez-Sell\u00e9s",
        "ForeName": "Manuel",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Geriatrics, Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands."
          }
        ],
        "LastName": "Mattace-Raso",
        "ForeName": "Francesco",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Brighton and Sussex Medical School, University of Sussex, Brighton, UK."
          }
        ],
        "LastName": "Rajkumar",
        "ForeName": "Chakravarthi",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Geriatrics and Intensive Care Unit, University of Florence and Azienda Ospedaliero Universitaria Careggi, Firenze, Italy."
          }
        ],
        "LastName": "Ungar",
        "ForeName": "Andrea",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Heart Center Trier, Krankenhaus der Barmherzigen Br\u00fcder, Trier, Germany."
          }
        ],
        "LastName": "Werner",
        "ForeName": "Nikos",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Helsinki University and Helsinki University Hospital, Haartmaninkatu 4, PO Box 340, N00029, Helsinki, Finland. timo.strandberg@oulu.fi."
          },
          {
            "Identifier": [],
            "Affiliation": "University of Oulu, Center for Life Course Health Research, Oulu, Finland. timo.strandberg@oulu.fi."
          }
        ],
        "LastName": "Strandberg",
        "ForeName": "Timo E",
        "Initials": "TE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "CollectiveName": "EuGMS Special Interest Group inCardiovascular Medicine (Chairpersons A. Ungar and A. Benetos)"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Eur Geriatr Med",
    "NlmUniqueID": "101533694",
    "ISSNLinking": "1878-7649"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Angiotensin Receptor Antagonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Angiotensin-Converting Enzyme Inhibitors"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Angiotensin Receptor Antagonists"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Angiotensin-Converting Enzyme Inhibitors"
    },
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Cardiovascular Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Renin-Angiotensin System"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "Other authors report no further conflicts of interest related to this paper."
}